Supplements
ADC Drug Conjugate Market Hits $42.55B Forecast by 2035
Antibody-drug conjugate expansion signals broader targeted-delivery innovation that nutraceutical formulators are watch…
Supplements 17 stories
Supplements
Betterbrand Targets Wildfire Smoke Exposure With Respiratory Supplement
Wildfire particulate exposure is emerging as a functional-foods category trigger, with brands eyeing lung-support and a…
Supplements
Neuroplasticity Pioneer Merzenich Wins Merkin Prize for Cochlear Work
Merzenich's neuroplasticity framework is foundational to the fast-growing cognitive supplement and digital therapeutics…
Supplements
World Blood Donor Day: Industry Backs Donation Awareness Push
The coalition push highlights growing intersections between blood health, iron status nutrition, and functional supplem…
Supplements
Mitapivat Phase 3 Data Highlights Anti-Hemolytic Mechanism in SCD
Pyruvate kinase activation as a therapeutic mechanism draws renewed attention as clinical-stage data surfaces at a majo…
Supplements
Morning Kick Blends Probiotics, Collagen & Adaptogens in One RTM Scoop
Multi-functional formats are reshaping the supplement beverage aisle as operators seek all-in-one finished formulations…
Supplements
Roxadustat Phase 3 Data Flags Anemia Pathway for Nutraceutical Formulators
As pharma advances HIF-PHI anemia mechanisms, functional-food and supplement brands targeting iron bioavailability and …
Supplements
Sleep.ai Brings 10 Studies to SLEEP 2026 for Product Validation
The SLEEP/APSS annual meeting offers a high-visibility stage for nutraceutical and device brands seeking clinical credi…
Supplements
OraSure FDA Clearance Expands At-Home STI Testing Access
The clearance signals continued regulatory momentum for consumer-directed diagnostics, a category intersecting with pre…
Supplements
Medicenna Expands U.S. Patent Portfolio Across IL-2, IL-4 & IL-13 Platforms
Portfolio now exceeds 100 active granted patents and applications globally, reinforcing IP barriers in the competitive …
Supplements
Tectonic Therapeutic Completes Enrollment in TX45 Phase 2 Trial
The GPCR-targeting therapeutic protein enters mid-stage evaluation in a severe cardiopulmonary subpopulation — but this…
Supplements
Harrow Re-Launches Cyclosporine Eye Emulsion for Pediatric VKC
The prescription re-entry addresses a documented gap in pediatric ophthalmic allergy care, though the product falls out…